[ad_1] KUALA LUMPUR: Duopharma Biotech Bhd is looking at a gradual recovery in revenue as it continues to strengthen its portfolio with high-value innovative offerings and niche products. Group managing…
Tag: Duopharma
Duopharma expects operational costs to rise in 2023
[ad_1] PETALING JAYA: Duopharma Biotech Bhd, which wrapped up financial year 2022 (FY22) on a strong note with record high revenue and net profit, expects operational costs to increase in…